A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis
NCT04243486 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2020-07-09
Summary
This study is to compare the safety and efficacy of UHE-105 Shampoo with that of the vehicle (VEH) Shampoo in subjects with scalp psoriasis. Half of the subjects will receive the UHE-105 Shampoo, while the other half will receive the VEH Shampoo with no active drug.
Conditions
- Scalp Psoriasis
Interventions
- DRUG
-
UHE-105
Topical shampoo containing active drug
- DRUG
-
Vehicle
Topical shampoo containing no active drug
Sponsors & Collaborators
-
Therapeutics, Inc.
lead INDUSTRY
Principal Investigators
-
Tony Andrasfay · Therapeutics, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-02
- Primary Completion
- 2020-06-15
- Completion
- 2020-06-15
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis
NCT04839016 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis
NCT02267135 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis
NCT05478499 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT01483924 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies
NCT00688519 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis
NCT03759197 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp
NCT00669214 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess S011806 (DC-806 or LY4100504) in Healthy Adult Participants and Participants With Chronic Plaque Psoriasis
NCT06808815 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
NCT03145948 ·Status: TERMINATED ·Phase: PHASE1
-
Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis
NCT00770965 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545
NCT00472758 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies
NCT00689481 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis
NCT03337022 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of AbGn-168 in Psoriasis
NCT00848055 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Participants With Chronic Plaque Psoriasis
NCT03922607 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD
NCT06345404 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis
NCT04123795 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118
NCT06846710 ·Status: RECRUITING ·Phase: PHASE1
-
A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis
NCT03710681 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis
NCT03424629 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00646191 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate the Safety, Tolerability, Absorption, Distribution, Metabolism, and Elimination of RWJ-445380 Administered to Patients With Plaque Psoriasis
NCT00396422 ·Status: COMPLETED ·Phase: PHASE2
-
A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 (Dalazatide) in Active Plaque Psoriasis
NCT02435342 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis
NCT06005792 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy
NCT00245765 ·Status: COMPLETED ·Phase: PHASE2